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Abstract 
Background:  EtCO2 variation has been advocated replacing cardiac output measurements to evaluate fluid respon‑
siveness (FR) during sepsis. The ability of EtCO2 variation after a fluid challenge to detect FR in the context of general 
anaesthesia has not been investigated. Forty patients were prospectively studied. They underwent general anaes‑
thesia for major surgeries. CO was measured by transoesophageal Doppler, and EtCO2 was recorded as well as other 
haemodynamic parameters [heart rate (HR), mean arterial pressure (MAP), pulse pressure (PP)] at baseline, after 100‑ml 
fluid load over 1 min, and at the end of the 500‑ml fluid load. We measured the variation of EtCO2 at 100 (ΔEtCO2100) 
and 500 ml (ΔEtCO2500), and ROC curves were generated. A threshold for ΔEtCO2 to predict FR was determined with 
receiver operating curves (ROC) analysis. The primary end point was the ability of EtCO2 variation after a 500‑ml fluid 
load to diagnose FR.
Results: Fifteen patients (38 %) were fluid responders. ROC analysis showed that for a threshold of 5.8 % (ΔEtCO2500), 
sensitivity was 0.6 IC 95 % [0.33; 0.86] and specificity was 1.0 IC 95 % [1.0; 1.0]. An absolute increase of more than 
2 mmHg of EtCO2 is specific to diagnose fluid responsiveness (spe = 96 [88–100] %, sens = 60 [33–88] %, AUC = 0.80 
[0.96–0.65]). HR, MAP, and PP variations and ΔEtCO2100 did not bring information to predict or diagnose FR. During 
fluid challenge, the correlation between CI variation and EtCO2 variation was r = 0.566, p < 0.001.
Conclusions:  During surgery, when alveolar ventilation and CO2 production are constant, ΔEtCO2500 is fairly reliable 
to assess FR. When the variation of EtCO2 is >5.8 %, all patients were responders, but no conclusion could be done 
when this variation was <5.8 %. ΔEtCO2100 failed to predict FR.
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Background
Excess or lack of fluid can be harmful in the periopera-
tive context. Strategies based on cardiac output optimisa-
tion have shown to improve outcome in different kinds 
of surgeries [1]. The Frank–Starling law implies that the 
heart of a patient working during the ascending part of 
the curve will improve cardiac output with an increase 
in preload: volume responsiveness (VR). Conversely, the 
heart of a patient working in the range of the plateau 
of the curve will not improve CO: volume non-respon-
siveness [2]. Fluid loading is the way to increase preload 
[3]. Volume responsiveness markers, such as direct car-
diac output monitoring or surrogate markers, have been 
implemented to adjust the amount of fluid to a patient’s 
needs. Static measures such as mean arterial pressure 
(MAP), pulse pressure (PP), heart rate (HR), and central 
venous pressure (CVP) cannot predict fluid responsive-
ness accurately. Dynamic parameters have been devel-
oped and have shown to be accurate [4–6]. Parameters 
Open Access
*Correspondence:  matthias.jl@gmail.com 
1 Service d’Anesthésie Réanimation, Centre Hospitalier Lyon Sud, Hospices 
Civils de Lyon, 165 Chemin du Grand Revoyet, 69495 Pierre‑Bénite, France
Full list of author information is available at the end of the article
Page 2 of 9Jacquet‑Lagrèze et al. Ann. Intensive Care  (2016) 6:37 
based on heart and lung interactions are limited by their 
dependence on relatively large tidal volumes, arrhyth-
mias, or the need for an arterial line [7]. Passive leg rais-
ing (PLR) is not convenient during surgery. Mini-fluid 
challenges have been described as a reliable method to 
predict VR if cardiac output is monitored [8]. Another 
approach is to perform a fluid challenge and assess a pos-
teriori its effectiveness. Even though some of published 
studies show that PP, HR, or MAP variations do not give 
valuable information about VR after volume expansion; 
a majority of anaesthesiologists still use these param-
eters to assess VR. This can be explained by the fact that 
cardiac output monitoring is thought to be too invasive 
[9]. The end-tidal carbon dioxide (EtCO2) correlates 
with cardiac output in experimental settings [10]. EtCO2 
variation has been recently used to assess cardiac out-
put variation during PLR and allows one to predict fluid 
responsiveness of septic patients in intensive care units 
[11, 12].
Measuring EtCO2 might be a reliable method to assess 
the effect of a fluid challenge in the operating room when 
cardiac output monitoring is not available. But this strat-
egy has not been prospectively evaluated during gen-
eral anaesthesia with a population including non-septic 
patients. The correlation between EtCO2 and CI has been 
shown to be stronger in a context of circulatory insuffi-
ciency than in a normal haemodynamic state [10]. The 
primary end point was the ability of EtCO2 variation after 
a 500-ml fluid load to diagnose fluid responsiveness. Sec-
ondary end points were to test whether changes in EtCO2 
during volume expansion correlate with changes in car-
diac output and the ability of the mini-fluid challenge 
(100 ml) to predict fluid responsiveness.
Methods
Our institution review board (Comité de Protection des 
Personnes Lyon Est III ref: 2013-027 B, ANSM Number 
ID RCB : 2013-A00729-36) approved the study protocol 
and waived signed informed consent. Inform consent 
was obtained and notified in the medical record.
Participants
The study was conducted over a 2.5-month period in 
2013 in a secondary care university hospital in Lyon. 
Participants were those admitted for emergency surgery 
with a high risk of haemodynamic disorders.
The decision to administer a fluid bolus for volume 
expansion was left to the discretion of the attending 
anaesthesiologist.
Inclusion criteria were patient undergoing general 
anaesthesia with mechanical ventilation and monitored 
with an oesophageal Doppler. The attending anaesthe-
siologist decision to administer a fluid bolus for volume 
expansion was a prerequisite for the inclusion of the 
patient. The need of oesophageal Doppler monitoring 
was defined in our setting as patients undergoing high-
risk surgeries or high-risk patients. High-risk surgeries 
were hip fractures, peritonitis, and abdominal haemo-
static surgery. High-risk patients were patients with heart 
failure or significant arteriopathy. Exclusion criteria were 
patient refusal age <18  years, pregnancy, fluid overload 
before anaesthesia, patients undergoing laparoscopic 
surgery, and patients with no available Doppler signals 
or contraindications to this monitoring technique. All 
patients meeting the inclusion criteria were included in 
the study except if they refused to participate if Doppler 
signal was lacking, or if principal investigators were not 
available.
Experimental design
Fluid volume expansion was performed, during the sur-
gery (after the induction of anaesthesia and placement of 
different monitoring devices). All the data were prospec-
tively recorded, and fluid responsiveness was determined 
after the fluid bolus and calculated afterthought. The 
experimental design is detailed in Fig. 1. The manuscript 
is written to fit with the STARD statement, to allow read-
ers to assess internal and external validity [13].
Fluid used and administration
Hydroxyethyl starch (Fresenius Kabi, Germany) was 
used. A total of 500 ml divided into one bolus of 100 ml 
and remaining 400 ml were administered. The first fluid 
bolus of 100 ml was administered at a rate of 100 ml in 
1 min (verified using a stopwatch) using a 50-ml syringe. 
After 1 min, the remaining 400 ml was administered over 
11 min. During the 13 min of fluid administration, there 
was no modification of the ventilatory settings. Also, no 
bolus or change in the rate of administration of vasocon-
strictor and anaesthetic agents was performed during 
this period.
Cardiac output monitoring
Patients were routinely monitored with a transoe-
sophageal Doppler probe (HemoSonic™ 100, ARROW 
International®, 61  mm length, <7-mm section.  5  MHz 
transducer) which enables recording of continuous 
descending aortic blood velocity, aortic diameter, aor-
tic ejection volume, aortic blood flow, and other valu-
able parameters such as acceleration of the flow (Acc) 
and systolic flow time corrected by heart rate (Ftc). Acc 
has been described to reflect inotropic change [14], 
and Ftc has been incorrectly described as a measure 
of left ventricular preload [15]. An algorithm enables 
cardiac output computation. The same observer (MJL) 
performed placement of the probes for all patients. 
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MJL had a good experience with oesophageal monitor-
ing with more than 2-year practice and more than 200 
examinations performed. Aortic diameter was visual-
ised and sampled by the transoesophageal probe. The 
Doppler probe was inserted through the mouth to 
the place where the maximal aortic blood flow veloc-
ity signal could be captured. The quality of the signal 
was assessed by the visualisation of the two walls of the 
aorta, and a consistent aortic diameter [16]. Doppler-
derived indices were averaged on ten systolic ejec-
tions. Cardiac index was calculated as CO divided by 
body surface. Measurements were recorded before fluid 
challenges to assessing variability and the least signifi-
cant change (LSC).
EtCO2 monitoring
The Infinity® EtCO2 Microstream SmartPod device was 
used to monitor EtCO2, a side stream device based on 
infrared absorption of a specific wavelength. This tech-
nology provides measures of EtCO2. The instantaneous 
values were recorded at 0, 1, and 13 min.
Other data and monitoring
Perioperative monitoring included continuous electro-
cardiogram, pulse oximetry, and non-invasive blood 
pressure every 5  min. Systolic, diastolic, and mean 
arterial pressures were recorded. Pulse pressure (PP), 
defined by systolic minus diastolic pressures, was cal-
culated. Airway pressure, peak pressure, plateau pres-
sure, respiratory rate, and tidal volume were monitored 
as well as partial inspiratory pressures of O2 and CO2. 
The end-tidal anaesthetic agent concentration of desflu-
rane or sevoflurane was monitored to assess deepness of 
anaesthesia.
Reference standard
Patients with more than a 15 % increase in cardiac index 
with a 500-ml fluid load were defined as fluid responders 
(R), the others being non-responders (NR) This definition 
is consistent with many diagnosis accuracy studies of fluid 
responsiveness. The observer was blind from the reference 
standard as fluid responsiveness was determined after the 
end of the fluid challenge and was calculated a posteriori.
Statistical analysis
We calculated with the method of Obuchowsky et al. [17] 
that 39 patients were needed in order to detect an area 
under the ROC curve of 0.75 with a power of 0.9 and 
an alpha risk of 0.05. The ratio between responder and 
non-responder in the studied population was 0.77. Nor-
mal distribution was tested by the d’Agostino–Pearson 
test. Pairwise comparisons of values were made with the 
paired Student’s t test or Wilcoxon test. The two-tailed 
Student t test or Mann–Whitney U test was performed 
for comparisons between responders and non-respond-
ers. In cases of relevancy, data were expressed as varia-
tions from baseline computed as the difference between 
final and baseline value divided by the baseline value and 
expressed as ΔCI and ΔEtCO2 for CI and EtCO2 varia-
tion. Correlations were tested by the Spearman method. 
The relationships between variables underwent linear 
regression analysis method. Before volume expansion, 
multiple measurements were recorded during steady 
haemodynamic and respiratory conditions defined as 
no need of vasoconstrictor, fluid challenge, and also 
no respiratory setting modification and no spontane-
ous breathing detected on the respirator. To assess the 
reproducibility of the reference standard and the evalu-
ated test, we performed ten successive measures during a 
Fig. 1 Experimental design. Data were collected at 0, 1, and 13 min. Mean arterial pressure (MAP), systolic arterial pressure (SAP), diastolic arterial 
pressure (DAP), corrected systolic flow time (Ftc), and end‑tidal carbon dioxide (EtCO2)
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stable haemodynamic period. The coefficient of variation 
was calculated as the standard deviation divided by the 
mean. The precision was twice the coefficient of varia-
tion, and the LSC was computed as 1.96 times the square 
root time the coefficient of error [18]. The LSC was the 
minimum change that can be considered as a real change. 
Data were expressed as mean ± standard deviation (SD) 
or as median [interquartile range: IQR] when appropri-
ate. ROC curves were built, and AUC was expressed as 
95  % confidence interval. Confidence interval was built 
with the “bootstraps” technique with 2000 repetitions 
and the same ratio between case and control.
ROC curves were then compared by the Delong test to 
a 0.5 built ROC curve [19]. Then, ROC curves were used 
to define three classes of response: negative, inconclusive, 
and positive. These classes were defined by the author to 
implement a 10  % diagnosis tolerance in the analysis as 
it is proposed in a grey zone approach. An EtCO2 varia-
tion with a value lower than the 90 % sensitivity threshold 
was defined as negative. An EtCO2 variation greater than 
the 90  % specificity threshold was defined as positive. 
Remaining EtCO2 variations were defined as inconclu-
sive. The proportion of the study population within these 
limits was calculated. Statistical analysis was performed 
with R Packages, referenced below [20]. Significant 
results were defined by a p value <0.05.
Results
All patients who met inclusion criteria were screened 
(Fig. 2). Patient characteristics are given in Table 1. The 
patients were scheduled for orthopaedic (65  %) and 
abdominal surgery (35 %). All patients underwent general 
anaesthesia with mechanical ventilation without sponta-
neous breathing at the time of the study. Twelve patients 
had surgery in a context of sepsis and nine had a previ-
ous history of cardiac failure (Table 1). The precision of 
EtCO2 was 2.2 ± 1.3 %, and the LSC was 3.2 ± 0.2 %. We 
did not deplore any adverse events as a consequence of 
the Doppler monitoring or EtCO2 measurements. We did 
not have any missing values of EtCO2 or CO at the three 
different times of the study. 
Responders and non‑responders
Fifteen patients (38 %) were considered to be fluid respond-
ers after a 500-ml bolus. CI increased in all patients by 
7.8 [3.1; 20.0]  %, in R group by 32 [20; 42]  %, and in NR 
groups, by 3.7 [0; 7.2] %. Distribution of EtCO2 variations in 
responders and non-responders is described in Fig. 3.
Fig. 2 Flowchart of patient recruitment. Cardiac index (CI), end‑tidal carbon dioxide (EtCO2)
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Description of the Variation of CI and EtCO2, pulse 
pressure, heart rate, Ftc, ventilatory change and end‑tidal 
anaesthetic agent concentration during volume expansion
Baseline haemodynamic and respiratory parameters were 
not significantly different between fluids responders and 
non-responders (Table 2). No significant differences were 
found for Vt and minute ventilation between before and 
after fluid expansion and between both groups at each 
moment (Table 2). The end of the trial, after the 500-ml 
volume expansion, showed a significant increase in CI 
and EtCO2 in the responders group and the Ftc increased 
in both groups (Table  2). The end-tidal anaesthetic 
agent concentration of desflurane or sevoflurane varia-
tion between before and after the fluid challenge was 2.6 
[−1.8; 11.4] % in the R group and 0 [0; 11.1] % in the NR 
group with no significant difference (p = 0.9).
Correlation between EtCO2 and CI
The Spearman correlation test between CI and EtCO2 
was not significant (r  =  0.178, p  =  0.272). However, 
there was a significant correlation (r = 0.566, p < 0.001) 
between CI variation (ΔCI) and EtCO2 variation 
(ΔEtCO2). The slope of the linear regression was 0.172.
Ability of ΔEtCO2 to predict fluid responsiveness after a 
mini‑fluid challenge (100 ml)
The correlation between EtCO2 variation and CI variation 
after a 100-ml fluid challenge was significant: r  =  0.39, 
p  =  0.013. The change in EtCO2 after a 100-ml infu-
sion provided an AUC-ROC =  0.74 [0.60; 0.89]; thresh-
old = 3.0 %; sens = 33 [13–60] %, spe = 100 [100–100] %.
Ability of ΔEtCO2 to diagnose fluid responsiveness after a 
500‑ml volume expansion
The area under the receiver operating characteristic 
curve (ROC-AUC), sensitivity, specificity, positive pre-
dictive value, and negative predictive value likelihood 
ratios are given in Table 3. ΔEtCO2 after a 500-ml expan-
sion (ΔEtCO2500) was able to diagnose fluid responsive-
ness with a threshold of 5.8 %. In a pragmatic approach, 
an absolute increase of more than 2  mmHg of EtCO2 
can diagnose fluid responsiveness (spe = 96 [88–100] %, 
sens  =  60 [33–88]  %, AUC  =  0.80 [0.96–0.65]). The 
AUC-ROC for heart rate variation (ΔHR500), MAP 
Table 1 Characteristics of the population studied
Data are expressed as median and [25th–75th] or as number and proportion of 
patients (n = 40). Body mass index (BMI), chronic obstructive pulmonary disease 
(COPD), positive end‑expiratory pressure (PEEP), fraction of inspired oxygen 
(FiO2), end‑tidal carbon dioxide (EtCO2), arterial oxygen partial pressure (PaO2), 
arterial carbon dioxide partial pressure (PaCO2), pulse oxygen saturation (SpO2), 
total intravenous anaesthesia (TIVA), vasoconstrictor (VC)
Characteristics N = 40
Age (years) 75 [57–92]
Male sex 17 (43)
Weight (kg) 69 [51–86]
Height (cm) 166 [156–177]
BMI (kg m−2) 25 [20–30]
Surgery
 Orthopaedic surgery 26 (65)
 General surgery 14 (35)
Sepsis 12 (30)
Antecedent
 ASA score 2.0 [1.6–2.8]
 Atrial fibrillation 5 (13)
 Cardiac failure 9 (23)
 COPD 4 (10)
Treatment prior surgery
 Beta blockers 12 (30)
 Other antiarrhythmic agents 5 (13)
Ventilation
 Tidal volume (ml kg−1) 6.6 [4.9–8.4]
 PEEP (cmH20) 5 [4–7]
 FiO2 (%) 58 [50–70]
 EtCO2 (mmHg) 31 [28–34]
 SpO2 (%) 99 [97–100]
Anaesthesia protocol
 Sufentanil 39 (98)
 Propofol TIVA 5 (13)
 Halogenated 35 (88)
 Curare 16 (40)
 Regional anaesthesia 14 (35)
Vasoconstrictors
 Vasoconstritor use 11 (28)
 Phenylephrine (µg kg−1 min−1) 0.2 [0.0–0.3]
Fig. 3 EtCO2 variation in responder and non‑responder. Variation of 
end‑tidal carbon dioxide after 500 ml (ΔEtCO2‑500 ml), responders (R) 
defined as patients who increased cardiac index more than 15 % after 
fluid expansion and non‑responders (NR) defined as patients who 
increased cardiac index <15 % after fluid expansion
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variation (ΔMAP500), and PP variation (ΔPP500) was not 
significantly different from 0.5. ROC curve of ΔHR500, 
ΔMAP500 and ΔEtCO2500 is shown in Fig. 4.
Clinical ranking of the response with a 10 % diagnosis 
tolerance
After a 500-ml fluid load, EtCO2 variation within the 
population can be classified as follows: 10 patients had 
a negative test, 10 patients had a positive test, and 20 
patients had an inconclusive test.
Discussion
This study shows that in a context where alveolar ven-
tilation and CO2 production are constant, the change 
in EtCO2 provides information to assess the CI changes 
during a 500-ml volume expansion. EtCO2 variation after 
a mini-fluid challenge is probably not usable to predict 
the response to a fluid bolus of 500 ml.
Three factors can explain a change in EtCO2: pulmo-
nary blood flow (usually equal to cardiac output), CO2 
metabolic production, and alveolar ventilation [21]. Nat-
urally, if two of these factors are constant, the change in 
Table 2 Haemodynamic data before  and after  a 500-ml 
fluid load in responders and non-responders
Comparison of responders (R) and non‑responders (NR): two‑tailed Wilcoxon’s 
rank test was performed between variables to compare before and after fluid 
expansion. Mann–Whitney U test was performed to compare responders to non‑
responders. Signs # for significant results comparing R and NR. Significant results 
comparing before and after fluid expansion are given by p value. Heart rate (HR), 
mean arterial pressure (MAP), diastolic arterial pressure (DAP), systolic arterial 
pressure (SAP), pulse pressure (PP), corrected systolic flow time (Ftc), cardiac 
index (CI), end‑tidal carbon dioxide (EtCO2), and minute ventilation (MV). Data 
are expressed as median and [25th–75th]
T0 T500 ml p value
HR (min−1)
 R 69 [65; 75] 73 [66; 76] 0.27
 NR 69 [61; 77] 70 [63; 74] 0.33
MAP (mmHg)
 R 59 [51; 66] 67 [55; 83] 0.12
 NR 63 [58; 67] 64 [56; 72] 0.47
SAP (mmHg)
 R 91 [84; 99] 111 [92; 115] 0.08
 NR 95 [88; 107] 95 [90; 112] 0.40
DAP (mmHg)
 R 50 [41; 54] 55 [44; 66] 0.07
 NR 50 [47; 56] 53 [45; 60] 0.60
PP (mmHg)
 R 44 [39; 51] 49 [41; 61] 0.16
 NR 46 [37; 51] 44 [40; 60] 0.42
Ftc (s/√s)
 R 312 [296; 329] 331 [325; 371] <0.01
 NR 305 [289; 322] 334 [303; 369] <0.01
EtCO2 (mmHg)
 R 31 [30, 32] 33 [31; 33] 0.02
 NR 32 [29; 34] 31 [28, 32]# 0.04
MV (L/min)
 R 5.1 [4.4; 6.9] 5.2 [4.4; 6.9] 0.52
 NR 6.4 [5.8; 7.2] 6.4 [5.7; 7.3] 0.81
Table 3 Main characteristics of ROC curves built for hemodynamic variables of interest
Mean arterial pressure (MAP), pulse pressure (PP), heart rate (HR), corrected systolic flow time (Ftc), and end‑tidal carbon dioxide (EtCO2). Data are expressed as 
variation from baseline (i.e., ΔEtCO2 for EtCO2 variation) after different volumes of infused fluid: 100 and 500 ml. Area under the curve (AUC), positive predictive value 
(PPV), negative predictive value (NPV), positive likelihood ratio (LR+), negative likelihood ratio (LR−)




Specificity Sensitivity PPV NPV LR+ LR− Youden 
index
varEtCO2500 0.82 [0.67; 0.97] 5.89 0.006 1 [1.0; 1.0] 0.6 [0.33 0.87] 1.0 0.81 Infinite 0.4 0.6
varEtCO2100 0.74 [0.60; 0.89] 3.0 0.034 1 [1.0; 1.0] 0.33 [0.13; 0.6] 1.0 0.68 Infinite 0.67 0.33
varMAP500 0.62 [0.44; 0.83] 0.31
varPP500 0.62 [0.43; 0.82] 0.31
varHR500 0.65 [0.44; 0.82] 0.29
FtC 0.49 [0.37; 0.67] 0.09
Fig. 4 ROC curves of EtCO2, MAP, and HR variation to assess fluid 
responsiveness after a 500‑ml fluid load. Mean arterial pressure (MAP), 
end‑tidal carbon dioxide (EtCO2), and heart rate (HR) variation after 
500‑ml fluid load to diagnose responders (R). ΔEtCO2, ΔMAP, and ΔHR 
are the variation % of each hemodynamic parameter after a 500‑ml 
fluid load
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the third factor can explain the variation of EtCO2. Two 
mechanisms can also explain EtCO2 variation. First, a 
fluid challenge increases venous return and pulmonary 
blood flow; thus, a greater amount of CO2 delivery to 
the lungs and removal by alveolar ventilation should be 
observed. Second, a fluid challenge recruits collapsed 
pulmonary blood capillaries and, therefore, reduces West 
zones 1 and 2 and increases zone 3 [22]. Consequently, 
the ventilation/perfusion ratio decreases and dead space 
is reduced enabling more CO2 to be extracted by alveolar 
ventilation.
Our results are consistent with previously published 
studies. EtCO2 has been described to be able to track CI 
changes in experimental [10] and clinical settings [23]. 
Additionally, changes in EtCO2 have been used in many 
clinical situations as cardiac resuscitation for monitor-
ing blood flow generated by precordial compression 
[24] or assessing the prognosis of cardiac arrest [25, 
26]. Two recent studies focusing on patients with sep-
tic shock using PLR and volume expansion have shown 
a significant correlation between changes in EtCO2 and 
CI. Some anaesthesiologists already assess fluid respon-
siveness by measuring EtCO2 variation during a fluid 
challenge, though this strategy has not been specifically 
evaluated [27]. As previously described, the correlation 
between the absolute values of EtCO2 and CI was not 
significant. This is explained by the fact that except for 
very low CI, EtCO2 is mainly influenced by many other 
factors than CI. Of course, during the short meantime of 
a volume expansion, these factors can be considered as 
unchanged.
The threshold value of the EtCO2 variation after 500-
ml volume infusion was 5.8 %, or an increase of 2 mmHg, 
which is low, but EtCO2 is a very stable variable if no 
modification of ventilation or cell metabolism occurs, so 
even a small change can be significant. This idea is rein-
forced by the fact that the least significant change (LSC) 
is smaller than the best threshold for a 500-ml load. 
Moreover, this is about the same threshold as the previ-
ously published one [11, 12]. Again, the threshold is near 
the LSC, and it seems to us that it would be hard to use in 
the clinical settings for a 100-ml load.
In previous studies, the correlation between changes in 
EtCO2 and CI was stronger during PLR than during vol-
ume expansion [11, 12]. Three main explanations can be 
given.
First, a passive leg raising is shorter than a fluid chal-
lenge. This increases the risk of a confounding factor 
such as ventilation or metabolism variation to be present.
Second, the study protocol was applied during anaes-
thesia for a surgery and not in a context of circulatory 
insufficiency. The link between EtCO2 and CI is predicted 
to be weaker when there is no circulatory insufficiency 
[10].
Third, the preload increase induced by a mini-fluid 
challenge is inferior compared with a passive leg raising. 
Our results concerning the mini-fluid challenge are con-
sistent with a study performed recently in a population of 
septic patients [28]. From our point of view, as long as the 
fluid challenge is great enough and the infusion time is 
short, changes in EtCO2 could be used as a surrogate for 
CO changes.
As expected, HR, PP, and MAP variations were unable 
to predict fluid responsiveness. In a pragmatic approach, 
with a clinical 10 % tolerance of sensitivity and specificity, 
as in the grey zone model, we can only conclude for half 
of the patients. Of course, these results are poorly discri-
minant. Nevertheless, the discrimination is higher than 
with parameters mostly used to assess fluid responsive-
ness as MAP and HR.
We acknowledge that there are some limitations. The 
variation of EtCO2 could be explained by variation in 
VCO2 due to variation in the depth of anaesthesia, but 
we did not find a significant difference between both 
groups in the end-tidal anaesthetic agent concentration. 
We did not use a specific device to monitor the depth of 
anaesthesia. Nevertheless, end-tidal anaesthetic agent 
concentration remains the reference to assess depth of 
anaesthesia [29].
The weak correlation between EtCO2 variation, and 
CI variation after a mini-fluid challenge was largely 
explained by the imprecision of both measurements: 
in fact, at that same time the mean variation of CI and 
EtCO2 in the responder group is under the least signifi-
cant change in the EtCO2 and CI.
Our patients benefited from protective mechanical 
ventilation with positive end-expiratory pressure and low 
tidal volumes for its positive effect [30]. Consequently, 
we did not compare our data to pulse pressure variation 
(PPV) or stroke volume variation (SVV) because we set 
the tidal volume under 8 ml/kg. These settings make SVV 
or PPV unable to predict fluid responsiveness [6, 31].
The AUC-ROC after a 500-ml fluid load has a lower 
confidence interval which is below 0.75. Accordingly, our 
study has not sufficient power to exclude the fact that the 
AUC in the population is below this limit. Therefore, we 
cannot exclude the fact that EtCO2 variation after a 500-
ml fluid load could be of limited clinical interest accord-
ing to Ray et al. [32].
To conclude in a setting with a constant alveolar ven-
tilation and CO2 production, if no data on cardiac out-
put or pulse pressure variation are available, EtCO2 is 
the only parameter that was discriminant to assess fluid 
responsiveness. When the variation of EtCO2 is >5.8  %, 
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all patients were responders, but no conclusion could 
be done when this variation was <5.8 %. A 100-ml mini-
fluid challenge was not discriminant and cannot be used 
to predict fluid responsiveness regarding the least sig-
nificant change in the EtCO2. Conversely to widespread 
belief, MAP, PP, and HR variations were not accurate 
in predicting fluid responsiveness. The strategy of fluid 
expansion based on EtCO2 variation could be a part of a 
haemodynamic optimisation protocol regarding its high 
specificity and its tremendous advantage upon classical 
cardiac output monitoring to be non-invasive, at no addi-
tional cost, and available in all operating rooms.
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